A Practical Method for Detecting Prognostic <scp>CD57</scp> + T Cells in Head and Neck Cancer
These refined panels enhance the clinical utility of HD TEMRA proportion as a biomarker due to their technical and analytic ease. Implementation of HD TEMRA cell proportion as a clinical biomarker could aid in personalized HNSCC treatment planning.
Authors
- Brendan L. C. Kinney (ORCID: https://orcid.org/0000-0002-3516-3008)
- Nicole C. Schmitt (ORCID: https://orcid.org/0000-0002-0571-3531)
- Vikash Kansal (ORCID: https://orcid.org/0000-0002-8240-2112)
- Brianna Brammer (ORCID: https://orcid.org/0000-0002-3042-7326)
Institutions
- Emory University (US)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1002/hed.70074
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00